Eric D. Hsi

29.6k total citations · 1 hit paper
405 papers, 12.2k citations indexed

About

Eric D. Hsi is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Eric D. Hsi has authored 405 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 245 papers in Pathology and Forensic Medicine, 149 papers in Genetics and 146 papers in Oncology. Recurrent topics in Eric D. Hsi's work include Lymphoma Diagnosis and Treatment (240 papers), Chronic Lymphocytic Leukemia Research (102 papers) and Viral-associated cancers and disorders (75 papers). Eric D. Hsi is often cited by papers focused on Lymphoma Diagnosis and Treatment (240 papers), Chronic Lymphocytic Leukemia Research (102 papers) and Viral-associated cancers and disorders (75 papers). Eric D. Hsi collaborates with scholars based in United States, Canada and Germany. Eric D. Hsi's co-authors include Juraj Bodo, Jaroslaw P. Maciejewski, Brad Pohlman, Raymond R. Tubbs, Alexandru Almasan, Bruce D. Cheson, Brian T. Hill, Sin‐Ho Jung, Jeffrey L. Johnson and Serhan Alkan and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Eric D. Hsi

390 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

2011 439 citations Owen A. O’Connor, Barbara Pro et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Eric D. Hsi

Since Specialization

Citations

This map shows the geographic impact of Eric D. Hsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Hsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Hsi more than expected).

Fields of papers citing papers by Eric D. Hsi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Hsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Hsi. The network helps show where Eric D. Hsi may publish in the future.

Co-authorship network of co-authors of Eric D. Hsi

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Hsi. A scholar is included among the top collaborators of Eric D. Hsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Hsi. Eric D. Hsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trial in Progress - Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma 2024 ·Blood ·Anne Beaven, Susan M. Geyer, Jonathon B. Cohen, Tycel Phillips, Travis Dockter, Priyanka A. Pophali, Gita Thanarajasingam, Gina L. Mazza, Alvaro J. Alencar, Shira Dinner, Eric D. Hsi, M.X. Welliver, Daniel A. Nikcevich, Brad S. Kahl, Jonathan W. Friedberg, Nancy L. Bartlett, John P. Leonard	0
2	Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group 2023 ·Leukemia Research ·(unknown), Weina Chen, (unknown), Adam Bagg, Prasad Koduru, Kathryn Foucar, (unknown), (unknown), Heesun J. Rogers, Wayne Tam, Attilio Orazi, Eric D. Hsi, Robert P. Hasserjian, Sa A. Wang, Daniel A. Arber, Olga K. Weinberg	4
3	The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology 2023 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sylvia Hartmann, Stefan Dojcinov, Snježana Dotlić, Sarah E. Gibson, Eric D. Hsi, Wolfram Klapper, Monika Klimkowska, Socorro Marıá Rodríguez-Pinilla, Julia Richter, Elena Sabattini, Thomas Tousseyn, Daphne de Jong	4
4	Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity 2021 ·Journal of Clinical Pathology ·Aaron M. Gruver, (unknown), Bradley L. Ackermann, (unknown), Ryan D. Morrison, Juraj Bodo, Keith Lai, David C Gemperline, Eric D. Hsi, D.C. Liebler, Jochen Schmitz, Robert J. Benschop	5
5	Vacuolization of hematopoietic precursors: an enigma with multiple etiologies 2021 ·Blood ·Carmelo Gurnari, Simona Pagliuca, Lisa Durkin, (unknown), Hassan Awada, Sunisa Kongkiatkamon, (unknown), Eric D. Hsi, Hetty E. Carraway, Heesun J. Rogers, Valeria Visconte, Jaroslaw P. Maciejewski	54
6	Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study 2020 ·American Journal of Hematology ·Heesun J. Rogers, Xiaoqiong Wang, Yan Xie, Adam R. Davis, Beenu Thakral, Sa A. Wang, Gautam Borthakur, (unknown), Elizabeth Margolskee, (unknown), Madina Sukhanova, Adam Bagg, Carlos E. Bueso‐Ramos, Attilio Orazi, Daniel A. Arber, Eric D. Hsi, Robert P. Hasserjian	22
7	Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group 2019 ·Modern Pathology ·Olga K. Weinberg, Robert P. Hasserjian, Ezra Baraban, Chi Young Ok, Julia T. Geyer, (unknown), Jason H. Kurzer, Heesun J. Rogers, Valentina Nardi, Richard M. Stone, Jacqueline S. Garcia, Eric D. Hsi, Adam Bagg, Sa A. Wang, Attilio Orazi, Daniel A. Arber	25
8	LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates 2018 ·Cancer Research ·James W. Purcell, (unknown), Jonathan A. Hickson, Melvin Fox, Mien Sho, Lisa Durkin, Tamar Uziel, Rick Powers, Kelly Foster, Thomas McGonigal, (unknown), Josue Samayoa, Dong Zhang, Joann P. Palma, (unknown), Diane Hollenbaugh, Kurt Gish, Susan E. Morgan-Lappe, Eric D. Hsi, Debra T. Chao	136
9	MYD88 L265P Mutation in Lymphoid Malignancies 2018 ·Cancer Research ·Xinfang Yu, Wei Li, Qipan Deng, Ling Li, Eric D. Hsi, Ken H. Young, Mingzhi Zhang, Yong Li	81
10	T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas 2017 ·American Journal of Clinical Pathology ·Tanu Goyal, Beenu Thakral, Sa A. Wang, Carlos E. Bueso‐Ramos, Min Shi, Dragan Jevremović, William G. Morice, (unknown), Tracy I. George, (unknown), Siddharth Bhattacharyya, Adam Bagg, Heesun J. Rogers, Juraj Bodo, Lisa Durkin, Eric D. Hsi	13
11	Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma 2013 ·Journal of Clinical Pathology ·Emil Frei, Carlo Visco, Zijun Y. Xu‐Monette, S Dirnhofer, Karen Dybkær, Attilio Orazi, Govind Bhagat, Eric D. Hsi, J. Han van Krieken, Maurilio Ponzoni, Ronald S. Go, Miguel Á. Piris, Michael Møller, Ken H. Young, Alexandar Tzankov	19
12	Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) 2013 ·Journal of Clinical Oncology ·James L. Rubenstein, Eric D. Hsi, Jeffrey L. Johnson, Sin‐Ho Jung, Megan O. Nakashima, Barbara Grant, Bruce D. Cheson, Lawrence D. Kaplan	320
13	Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis 2013 ·The American Journal of Surgical Pathology ·Laszlo J. Karai, Marshall E. Kadin, Eric D. Hsi, Jason C. Sluzevich, Rhett P. Ketterling, Ryan A. Knudson, Andrew L. Feldman	126
14	Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study breakdown → 2011 ·Journal of Clinical Oncology ·Owen A. O’Connor, Barbara Pro, Lauren Pinter‐Brown, Nancy L. Bartlett, Leslie Popplewell, Bertrand Coiffier, Mary Jo Lechowicz, Kerry J. Savage, Andrei R. Shustov, Christian Gisselbrecht, Eric D. Jacobsen, Pier Luigi Zinzani, Richard R. Furman, André Goy, Corinne Haïoun, Michael Crump, Jasmine Zain, Eric D. Hsi, Adam P. Boyd, Steven M. Horwitz	439
15	Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities 2011 ·Blood ·Samar Farha, Kewal Asosingh, Weiling Xu, Jacqueline Sharp, Deepa George, Suzy Comhair, Margaret Park, W.H. Wilson Tang, James E. Loyd, Karl S. Theil, Raymond Tubbs, Eric D. Hsi, Alan Lichtin, Serpil C. Erzurum	107
16	Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms 2010 ·Clinical Cancer Research ·Patricia Culp, Donghee Choi, Yongke Zhang, Johnny Yin, Pui Seto, Suzanne E. Ybarra, (unknown), Mien Sho, Roxanne Steinle, Melanie Wong, (unknown), Jennifer Grove, (unknown), (unknown), Eric D. Hsi, Debra T. Chao, David B. Powers, Vanitha Ramakrishnan, Robert B. DuBridge	62
17	Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494 2010 ·Clinical Cancer Research ·Jane N. Winter, Shuli Li, (unknown), Daina Variakojis, Beverly P. Nelson, Maryla Krajewska, Lijun Zhang, Thomas M. Habermann, Richard I. Fisher, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, Edie Weller, Ari Melnick, John C. Reed, Sandra J. Horning, Randy D. Gascoyne	26
18	Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies 2009 ·Journal of Clinical Oncology ·Hideki Makishima, Heather Cazzolli, Hadrian Szpurka, Andrew Dunbar, Ramón V. Tiu, Jungwon Huh, Hideki Muramatsu, Christine L. O’Keefe, Eric D. Hsi, Ronald Paquette, Seiji Kojima, Alan F. List, Mikkael A. Sekeres, Michael A. McDevitt, Jaroslaw P. Maciejewski	150
19	Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study 2008 ·Leukemia & lymphoma ·Eric D. Hsi, Sin‐Ho Jung, Raymond Lai, Jeffrey L. Johnson, James R. Cook, Dan Jones, Sven deVos, Bruce D. Cheson, Lloyd E. Damon, Jonathan Said	87
20	Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma 2008 ·Modern Pathology ·(unknown), Uma Sundram, Yasodha Natkunam, Sabine Köhler, Richard T. Hoppe, Youn H. Kim, James R. Cook, (unknown), Steven H. Swerdlow, (unknown), Marc D. Smith, David Bosler, Catherine M. Listinsky, Izidore S. Lossos, Eric D. Hsi	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact